Related Experiment Videos
Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can
E Piek1, P Franzén, C H Heldin
1Department of Cell Biology, University of Nijmegen, The Netherlands. esterp@sci.kun.nl
Abstract:
We have characterized a 60-kDa transforming growth factor-beta (TGF-beta) binding protein that was originally identified on LNCaP adenocarcinoma prostate cells by affinity cross-linking of cell surface proteins by using 125I-TGF-beta 1. Binding of 125I-TGF-beta 1 to the 60-kDa protein was competed by an excess of unlabeled TGF-beta 1 but not by TGF-beta 2, TGF-beta 3, activin, or osteogenic protein-1 (OP-1), also termed bone morphogenetic protein-7 (BMP-7). In addition, no binding of 125I-TGF-beta 2 and 125I-TGF-beta 3 to the 60-kDa binding protein on LNCaP cells could be demonstrated by using affinity labeling techniques. The 60-kDa TGF-beta binding protein showed no immunoreactivity with antibodies against the known type I and type II receptors for members of the TGF-beta superfamily. Treatment of LNCaP cells with 0.25 M NaCl, 1 microgram/ml heparin, or 10% glycerol caused a release of the 60-kDa protein from the cell surface. In addition, we found that the previously described TGF-beta type IV receptor on GH3 cells, which does not form a heterometric complex with TGF-beta receptors, could be released from the cell surface by these same treatments. This suggests that the 60-kDa protein and the similarly sized TGF-beta type IV receptor are related proteins. The eluted 60-kDa LNCaP protein was shown to interfere with the binding of TGF-beta to the TGF-beta receptors. Thus, the cell surface-associated 60-kDa TGF-beta binding protein may play a role in regulating TGF-beta binding to TGF-beta receptors.
Insights
Researchers identified a 60-kDa transforming growth factor-beta (TGF-beta) binding protein on prostate cancer cells. This protein interferes with TGF-beta receptor binding, suggesting a role in regulating TGF-beta signaling.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGF-beta) is a crucial regulator of cell growth and differentiation.
- Understanding TGF-beta binding proteins is essential for elucidating its signaling pathways.
- Prostate adenocarcinoma cells (LNCaP) are utilized to study cell surface interactions.
Purpose of the Study:
- To characterize a novel 60-kDa TGF-beta binding protein on LNCaP cells.
- To determine the specificity and regulation of this binding protein.
- To investigate the functional role of the 60-kDa protein in TGF-beta signaling.
Main Methods:
- Affinity cross-linking using 125I-TGF-beta 1 to identify cell surface binding proteins.
- Competition assays with various TGF-beta isoforms and related proteins.
- Immunoreactivity testing against known TGF-beta receptor antibodies.
- Cell surface protein elution using salt, heparin, and glycerol treatments.
- Assessment of the eluted protein's effect on TGF-beta receptor binding.
Main Results:
- A 60-kDa protein on LNCaP cells specifically binds TGF-beta 1, but not TGF-beta 2 or 3.
- This protein is distinct from known TGF-beta type I and II receptors.
- The 60-kDa protein can be released from the cell surface by specific treatments.
- The released protein inhibits TGF-beta binding to its receptors.
- The 60-kDa protein shares characteristics with the TGF-beta type IV receptor.
Conclusions:
- A novel 60-kDa cell surface protein on prostate cancer cells binds TGF-beta 1.
- This protein may function as a regulator of TGF-beta bioavailability and receptor interaction.
- Further research into this protein could reveal new therapeutic targets for prostate cancer.